Carl Zeiss Meditec AG (OTCMKTS:CZMWY – Get Free Report) was the recipient of a significant decrease in short interest in July. As of July 15th, there was short interest totaling 37 shares, a decrease of 96.4% from the June 30th total of 1,033 shares. Based on an average daily trading volume, of 7,749 shares, the days-to-cover ratio is presently 0.0 days.
Analyst Upgrades and Downgrades
Separately, Zacks Research upgraded Carl Zeiss Meditec from a “strong sell” rating to a “hold” rating in a report on Monday, July 13th. One analyst has rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, Carl Zeiss Meditec has an average rating of “Hold”.
Check Out Our Latest Stock Report on CZMWY
Carl Zeiss Meditec Stock Up 1.1%
About Carl Zeiss Meditec
Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.
The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.
Featured Stories
- Five stocks we like better than Carl Zeiss Meditec
- Why Palantir Investors Aren’t Panicking While the Rest of AI Sells Off
- MarketBeat Week in Review – 07/20- 07/24
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
